Vitiligo clinical trials at University of California Health
4 in progress, 3 open to eligible people
AMG 714 for Vitiligo
open to eligible people ages 18-75
This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.
at UC Davis UC Irvine
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
open to eligible people ages 18 years and up
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
at UC Davis UC Irvine
Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
at UC Irvine UCSD
Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).
at UC Davis
Our lead scientists for Vitiligo research studies include Anand Ganesan, MD, PhD Victor Huang, MD Natasha Mesinkovska, MD Lawrence F Eichenfield, MD.
Last updated: